Cheung Tan To, Ma Ka Wing, She Wong Hoi, Dai Wing Chiu, Tsang Simon Hing Yin, Chan Albert Chi Yan, Chok Kenneth Siu Ho, Lo Chung Mau
Department of Surgery, The University of Hong Kong, Hong Kong.
Asian J Endosc Surg. 2018 May;11(2):104-111. doi: 10.1111/ases.12492. Epub 2018 May 10.
Laparoscopic hepatectomy is considered an acceptable treatment of choice in selected patients with primary hepatocellular carcinoma (HCC). Whether indocyanine green (ICG) immunofluorescence, a new technology, may improve surgery outcomes has yet to be tested. The aim of the present study was to investigate and compare the effect of ICG fluorescence imaging on the outcomes of pure laparoscopic hepatectomy and open hepatectomy for primary HCC with background cirrhosis.
From January 2015 to June 2016, 20 patients with HCC and liver cirrhosis underwent laparoscopic hepatectomy with ICG immunofluorescence. The outcomes of pure laparoscopic hepatectomy with ICG immunofluorescence were compared with those of open hepatectomy. To avoid selection bias, patients were propensity score matched in a ratio of 1 : 6, with 20 patients in the laparoscopic group and 120 in the open group.
The laparoscopic group had 20 patients, and the open group had 120 patients. The laparoscopic group had less blood loss (125 vs 450 mL, P < 0.001), a shorter operation time (200 vs 250 min, P = 0.003), and a shorter hospital stay (5 vs 6 days, P < 0.001). The complication rate was 0% in the laparoscopic group compared to 15.0% in the open group (P = 0.135). All patients in the laparoscopic group had negative margin involvement. Four patients (3.3%) in the open resection group had positive margin involvement. Two patients in the ICG immunofluorescence group had additional lesions identified and resected during operation.
Pure laparoscopic hepatectomy with ICG immunofluorescence for primary HCC can be carried out safely with favorable short-term outcomes even in cirrhotic patients. Better identification of the bile duct structure and better assessment of the tumor resection margin and perfusion are advantages of this new technique.
对于部分原发性肝细胞癌(HCC)患者,腹腔镜肝切除术被认为是一种可接受的治疗选择。新型技术吲哚菁绿(ICG)免疫荧光是否能改善手术效果仍有待验证。本研究旨在调查并比较ICG荧光成像对合并背景性肝硬化的原发性HCC患者行单纯腹腔镜肝切除术和开腹肝切除术效果的影响。
2015年1月至2016年6月,20例HCC合并肝硬化患者接受了ICG免疫荧光腹腔镜肝切除术。将ICG免疫荧光单纯腹腔镜肝切除术的结果与开腹肝切除术的结果进行比较。为避免选择偏倚,患者按1:6的比例进行倾向评分匹配,腹腔镜组20例,开腹组120例。
腹腔镜组20例患者,开腹组120例患者。腹腔镜组术中出血量更少(125 vs 450 mL,P < 0.001),手术时间更短(200 vs 250 min,P = 0.003),住院时间更短(5 vs 6天,P < 0.001)。腹腔镜组并发症发生率为0%,开腹组为15.0%(P = (此处原文有误,根据前文推测可能是0.135))。腹腔镜组所有患者切缘均无癌累及。开腹切除组4例患者(3.3%)切缘有癌累及。ICG免疫荧光组有2例患者在手术中发现并切除了额外病灶。
即使是肝硬化患者,采用ICG免疫荧光的单纯腹腔镜肝切除术治疗原发性HCC也可安全进行,且短期效果良好。该新技术的优点是能更好地识别胆管结构,更好地评估肿瘤切除切缘和灌注情况。